These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 4057042)

  • 1. Dose-dependent disposition of fractionated 3H-heparin in rats.
    Watanabe J; Hori K; Iwamoto K; Ozeki S
    J Pharmacobiodyn; 1985 Jun; 8(6):468-76. PubMed ID: 4057042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disposition of fractionated 3H-heparin in rats.
    Watanabe J; Hori K; Iwamoto K; Ozeki S
    J Pharmacobiodyn; 1983 Jun; 6(6):423-32. PubMed ID: 6631661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose-dependent uptake of radioactivity by liver parenchymal and non-parenchymal cells after intravenous administration of fractionated 3H-heparin to rats.
    Watanabe J; Haba M; Muranishi H; Yuasa H
    Biol Pharm Bull; 1993 Oct; 16(10):1031-4. PubMed ID: 8287033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macromolecule-macromolecule interaction in drug distribution: effect of alpha-globulin concentration on the hepatic uptake of fractionated 3H-heparin by perfused rat liver.
    Watanabe J; Muranishi H; Nakagaki H; Yuasa H; Ozeki S
    Chem Pharm Bull (Tokyo); 1990 Oct; 38(10):2821-4. PubMed ID: 1706227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation on interaction of fractionated 3H-heparin with plasma proteins by gel filtration chromatography.
    Watanabe J; Nakagaki H; Yuasa H; Ozeki S
    J Pharmacobiodyn; 1989 Jul; 12(7):416-22. PubMed ID: 2480440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disposition of tritium-labelled heparin in rats.
    Watanabe J; Hori K; Iwamoto K; Ozeki S
    J Pharmacobiodyn; 1982 Aug; 5(8):627-37. PubMed ID: 7153835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disposition and metabolism of double-labeled [3H and 14C] N-methyl-2-pyrrolidinone in the rat.
    Wells DA; Digenis GA
    Drug Metab Dispos; 1988; 16(2):243-9. PubMed ID: 2898341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absorption, distribution and excretion of 3H-labeled cephaeline- and emetine-spiked ipecac syrup in rats.
    Asano T; Ishihara K; Wakui Y; Yanagisawa T; Kimura M; Kamei H; Yoshida T; Kuroiwa Y; Fujii Y; Yamashita M; Kuramochi T; Tomisawa H; Tateishi M
    Eur J Drug Metab Pharmacokinet; 2002; 27(1):17-27. PubMed ID: 11996323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macromolecule-macromolecule interaction in drug distribution. II. Effect of alpha-globulin on saturable uptake of fractionated [3H]heparin by rat parenchymal hepatocytes in primary culture.
    Watanabe J; Muranishi H; Yuasa H; Ozeki S
    Chem Pharm Bull (Tokyo); 1992 Nov; 40(11):3052-5. PubMed ID: 1282443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutralization of heparin by histone and its subfractions.
    Pal PK; Starr T; Gertler MM
    Thromb Res; 1983 Jul; 31(1):69-79. PubMed ID: 6612698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macromolecule-macromolecule interaction in drug distribution. III. Kinetic characterization of the uptake of fractionated [3H]heparin and the effect of plasma proteins in the perfused rat liver.
    Watanabe J; Kondo H; Muranishi H; Urano K; Haba M; Yuasa H
    Biol Pharm Bull; 1993 Oct; 16(10):1035-9. PubMed ID: 8287034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uptake of fractionated 3H-heparin by isolated rat Kupffer cells.
    Watanabe J; Haba M; Yuasa H
    Pharm Res; 1995 Jul; 12(7):1092-5. PubMed ID: 7494808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and whole-body distribution of the new chemotherapeutic agent beta-D-glucosylisophosphoramide mustard and its effects on the incorporation of [methyl-3H]-thymidine in various tissues of the rat.
    Stüben J; Port R; Bertram B; Bollow U; Hull WE; Schaper M; Pohl J; Wiessler M
    Cancer Chemother Pharmacol; 1996; 38(4):355-65. PubMed ID: 8674159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of the leukotriene receptor antagonists FPL 55712, LY 163443, and MK-571 on the elimination of cysteinyl leukotrienes in the rat.
    Denzlinger C; Grimberg M; Kapp A; Haberl C; Wilmanns W
    Br J Pharmacol; 1991 Apr; 102(4):865-70. PubMed ID: 1855116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uptake of fractionated [3H]heparin by rat parenchymal hepatocytes in primary culture: effects of alpha-globulin, temperature, and pH.
    Watanabe J; Muranishi H; Yuasa H; Ozeki S
    J Pharm Sci; 1992 Jun; 81(6):513-7. PubMed ID: 1381747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absorption, distribution, metabolism and excretion of glucosamine sulfate. A review.
    Setnikar I; Rovati LC
    Arzneimittelforschung; 2001 Sep; 51(9):699-725. PubMed ID: 11642003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Metabolic fate of bufalin in rats].
    Toma S; Hirai Y; Sugimoto C; Shoji M; Oguni Y; Morishita S; Ito C; Horie M
    Yakugaku Zasshi; 1991 Nov; 111(11):676-86. PubMed ID: 1783982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism of liposome-encapsulated heparin.
    Kim TD; Kambayashi J; Sakon M; Tsujinaka T; Ohshiro T; Mori T
    Thromb Res; 1989 Nov; 56(3):369-76. PubMed ID: 2617476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Location of antithrombin-binding regions in rat skin heparin proteoglycans.
    Jacobsson KG; Lindahl U; Horner AA
    Biochem J; 1986 Dec; 240(3):625-32. PubMed ID: 3827857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing the plasma pharmacokinetics, tissue distribution, excretion and effects on cholesterol pharmacokinetics of a novel hydrophilic compound, FM-VP4, following administration to rats.
    Wasan KM; Peteherych KD; Najafi S; Zamfir C; Pritchard PH
    J Pharm Pharm Sci; 2001; 4(3):207-16. PubMed ID: 11737986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.